Hims&Hers Health Q3 earnings beat estimates, raises guidance

Investing.comNov 4, 2024 9:44 PM

View all comments（0）



Investing.com -- Hims Hers Health Inc (NYSE:HIMS) reported third-quarter earnings that surpassed analyst expectations and raised its full-year guidance, driven by strong subscriber growth and improving profitability.

The stock was up 2.5% following the earnings release.

The health and wellness platform posted adjusted earnings per share of $0.32, beating the analyst estimate of $0.10 by $0.22. Revenue for the quarter came in at $401.6 million, up 77% YoY and exceeding the consensus estimate of $382.2 million.

Hims&Hers saw its subscriber base grow to 2.0 million, a 44% increase YoY. The company noted that over 1 million subscribers are now utilizing personalized solutions.

"Our execution against a strategy that brings customers convenient, transparent, and affordable access to care designed specifically for them is allowing us to reach millions of individuals across the country," said Andrew Dudum, co-founder and CEO.

For the fourth quarter, Hims&Hers expects revenue between $465 million and $470 million, above the consensus of $421.1 million. The company raised its full-year 2024 revenue guidance to a range of $1.460 billion to $1.465 billion, up from the previous analyst consensus of $1.4 billion.

CFO Yemi Okupe highlighted the company's improving profitability, stating, "Our model is rapidly gaining scale, driving accelerating top line growth, improving profitability and strong cash flow."

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

Commenting Guidelines

Recommended Articles

Micron Stock Price Forecast: $250 Billion Investment Plan Boosts Sentiment, Stock Price Expected to Rise to $1,400 in July

TradingKey - As of July 9 ET, Micron Technology (MU) was trading at $991.64, up 4.42% for the day, with an intraday high of $1,035.00. Benefiting from the company's announced plan to expand investment in the U.S., the price correction may be ending, signaling the start of a new rally.

Palantir (PLTR) Stock Forecast: Nvidia Partnership, Burry Covered, Trump Bought - Is the Bottom In?

Palantir surged 9% on July 1 after a Nvidia AI partnership, Burry trimming his short, and Trump disclosing a $1M+ PLTR stake. DA Davidson upgraded to Buy at $175. At $127 down 27% YTD, is the rotation beginning?

Broadcom (AVGO) Stock Price Forecast: Apple’s $30B US Chip Deal Confirmed - Buy at $404?

Apple confirmed a $30B+ multiyear Broadcom chip deal for 15 billion US-made chips, including a $1.5B Colorado facility expansion. AVGO at $404, defying a broad selloff driven by Trump declaring the Iran ceasefire over

Japan and South Korea Stocks Open Strong: SoftBank Surges 7% to Lead, SK Hynix, Samsung and Kioxia All Rally Over 4%

Both the Japanese and South Korean stock markets opened sharply higher, with the Nikkei 225 and the KOSPI index continuing to surge. SoftBank soared nearly 7%, while SK Hynix, Samsung Electronics, and Kioxia all rose by over 4%.

Tesla Optimus Gen 3 Design Initially Finalized, Musk Sets Hard Target for Supply Chain: 1,000 Units Weekly Production by September.

TradingKey - According to reports from LatePost, multiple sources within Tesla's supply chain have revealed that Tesla recently issued specific procurement guidance for Optimus parts to its suppliers. The company requested that production capacity be increased to 1,000 units per week by September of this year, and further raised to between 2,000 and 2,500 units per week by the end of the year. Based on the year-end weekly capacity estimate, suppliers will have the capability to supply parts for approximately 100,000 Optimus units annually to Tesla by the end of the year.

Featured Tools